| European Case Law Identifier: | ECLI:EP:BA:2012:T007511.20120424 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 24 April 2012 | ||||||||
| Case number: | T 0075/11 | ||||||||
| Application number: | 02764081.2 | ||||||||
| IPC class: | C07D 401/12 A61K 31/4439 A61P 1/04 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Crystalline form of Omeprazole | ||||||||
| Applicant name: | LEK Pharmaceuticals d.d. | ||||||||
| Opponent name: | Quimica Sintetica. S.A. | ||||||||
| Board: | 3.3.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Late-filed documents not admitted by the opposition division Discretionary power exercised according to the right principles Evidence provided with the statement setting out the grounds of appeal - not admitted - should and could have been submitted before the first instance Remittal - (no) - Failure to present evidence in due time |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t110075eu1.html
Date retrieved: 17 May 2021